STOCK TITAN

ALR Technologies SG Ltd. (ALRTF) details GluCurve Pet CGM relaunch

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

ALR Technologies SG Ltd. filed a report as a foreign private issuer to share a recent company announcement. The filing states that on December 8, 2025, the company issued a press release, which is attached to the report as Exhibit 99.1.

The press release announced the relaunch of the company’s GluCurve Pet CGM, a continuous glucose monitoring product for pets. This report mainly serves to make that product update publicly available to investors through the SEC’s disclosure system.

Positive

  • None.

Negative

  • None.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December 2025

 

____________________       

 

Commission File Number: 000-56491

 

ALR Technologies SG Ltd.

(Translation of registrant’s name into English)

 

 

9 Raffles Place

#26-01 Republic Plaza

Singapore

Singapore 048619

(Address of principal executive office)

____________________

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

 
 

 

On December 8, 2025, ALR Technologies SG Ltd. issued a press release, a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K and incorporated by reference herein.

 

Exhibit Number Description of Exhibit
99.1 Press Release dated December 8, 2025, Announcing the relaunch of the GluCurve Pet CGM.

 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: December 30, 2025

 

ALR Technologies SG Ltd.

 

 

By: s/ Sidney Chan

Name: Sidney Chan

Title: CEO

 

 

 

 

 

 

FAQ

What did ALR Technologies SG Ltd. (ALRTF) report in this December 2025 filing?

The company reported that it issued a press release on December 8, 2025, announcing the relaunch of its GluCurve Pet CGM, and furnished that release as Exhibit 99.1.

What is the main business update disclosed by ALR Technologies SG Ltd. in this report?

The main update is the relaunch of the GluCurve Pet CGM, which the company highlighted in a press release dated December 8, 2025.

How is the GluCurve Pet CGM announcement included in the ALR Technologies (ALRTF) SEC filing?

The announcement is included as Exhibit 99.1, described as a press release dated December 8, 2025, announcing the relaunch of the GluCurve Pet CGM.

What type of SEC report did ALR Technologies SG Ltd. file for this disclosure?

ALR Technologies SG Ltd. filed a Form 6-K, which is a report used by foreign private issuers to furnish current information to investors.

Who signed the ALR Technologies SG Ltd. December 2025 report?

The report was signed on behalf of ALR Technologies SG Ltd. by Sidney Chan, who is identified as the company’s CEO.
Alr Technologies

OTC:ALRTF

ALRTF Rankings

ALRTF Latest News

ALRTF Latest SEC Filings

ALRTF Stock Data

7.70M
246.49M
61.21%
Medical Devices
Healthcare
Link
Singapore
Singapore